New insights into Vogt-Koyanagi-Harada disease;Novos conhecimentos sobre a doença de Vogt-Koyanagi-Harada

Arquivos Brasileiros de Oftalmologia

Volumn 72, Issue 3, 2009, Pages 413-420

  Damico, Francisco Max ^a   da Silva, Felipe Theodoro Bezerra Gaspar Carvalho ^a   Gasparin, Fábio ^a   Yamamoto, Joyce Hisae ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoimune diseases immunology; Chronic disease; HLA DR antigens; Melanocytes immunology; Review; Uveitis etiology; Uveomeningoencephalitic syndrome

Indexed keywords

HLA DR ANTIGEN; HLA DRB1*0405 ANTIGEN; HLA-DRB1*0405 ANTIGEN;

CHRONIC DISEASE; HUMAN; IMMUNOLOGY; MENINGOENCEPHALITIS; REVIEW;

CHRONIC DISEASE; HLA-DR ANTIGENS; HUMANS; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 70449698225     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/S0004-27492009000300028     Document Type: Article

References (40)

1. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995:39(4):265-92.
2. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report an international comittee on nomenclature. Am J Ophthalmol. 2001;131(5):647-52.
3. da Silva FT, Damico FM, Marin ML, Goldberg AC, Hirata CE, Takiuti PH, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: considerations on the different disease categories. Am J Ophthalmol. 2009;147(2): 339-45.
4. Cardoso IH, Zajdenweber ME, Muccioli C, Fimamor LP, Belfort R Jr. Applicability of the 2001 revised diagnostic criteria in Brazilian Vogt-Koyanagi-Harada disease patients. Arq Bras Oftalmol. 2008;71(1):67-70.
5. Suzuki S. Quantitative evaluation of "sunset glow" fundus in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1999;43(4):327-33.
6. Keino H, Goto H, Usui M. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation. Graefes Arch Clin Exp Ophthalmol. 2002;240(10):878-82.
7. Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol. 2007;27(2-3):173-82.
8. Maezawa N, Yano A, Taniguchi M, Kojima S. The role of cytotoxic T lymphocytes in the pathogenesis of Vogt-Koyanagi-Harada disease. Ophthalmologica. 1982;185(3):179-86.
9. Okada T, Sakamoto T, Ishibashi T, Inomata H. Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site. Graefes Arch Clin Exp Ophthalmol. 1996;234(6):359-63.
10. Sakaguchi M, Sugita S, Sagawa K, Itoh K, Mochizuki M. Cytokine production by T cells infiltrating in the eye of uveitis patients. Jpn J Ophthalmol. 1998;42(4):262-8.
11. Gocho K, Kondo I, Yamaki K. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 2001;42(9):2004-9.
12. Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, et al. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1 0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Invest Ophthalmol Vis Sci. 2005;46(7):2465-71.
13. Miyazawa I, Abe T, Narikawa K, Feng J, Misu T, Nakashima I, et al. Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease. J Neuroimmunol. 2005;158(1-2):240-4.
14. Chi W, Yang P, Li B, Wu C, Jin H, Zhu X, et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007;119(5):1218-24.
15. Chen L, Yang P, Zhou H, He H, Ren X, Chi W, et al. Diminished frequency and function of CD4+CD25 high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci. 2008; 49(8):3475-82.
16. Tagawa Y, Sugiura S, Yakura H, Wakisaka A, Aizawa M. Letter: HLA and Vogt-Koyanagi-Harada syndrome. N Engl J Med. 1976;295(3):173.
17. Davis JL, Mittal KK, Freidlin V, Mellow SR, Optican DC, Palestine G, et al. HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. Ophthalmology. 1990;97(9):1137-42.
18. Goldberg AC, Yamamoto JH, Chiarella JM, Marin ML, Sibinelli M, Neufeld R, et al. HLA-DRB1 0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol. 1998;59(3):183-8.
19. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol. 2000;165(12):7323-9.
20. Sugita S, Sagawa K, Mochizuki M, Shichijo S, Itoh K. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int Immunol. 1996;8(5):799-803.
21. Chan CC, Ying L, Sun B, Li Q, Matteson DM, Shen DF, et al. Recombinant adenovirus encoding gp100 modulates experimental melanin-induced uveitis (EMIU). J Autoimmun. 1998;11(2):111-8.
22. Yamaki K, Takiyama N, Itho N, Mizuki N, Seiya M, Sinsuke W, et al. Experimentally induced Vogt-Koyanagi-Harada disease in two Akita dogs. Exp Eye Res. 2005;80(2):273-80.
23. Otani S, Sakurai T, Yamamoto K, Fujita T, Matsuzaki Y, Goto Y, et al. Frequent immune response to a melanocyte-specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2006;90(6):773-7.
24. Matsuzaki Y, Hashimoto S, Fujita T, Suzuki T, Sakurai T, Matsushima K, et al. Systematic identification of human melanoma antigens using serial analysis of gene expression (SAGE). J Immunother. 2005;28(1):10-9.
25. Yamada K, Senju S, Shinohara T, Nakatsura T, Murata Y, Ishihara M, et al. Humoral immune response directed against LEDGF in patients with VKH. Immunol Lett. 2001;78(3):161-8.
26. Yamada K, Senju S, Nakatsura T, Murata Y, Ishihara M, Nakamura S, et al. Identification of a novel autoantigen UACA in patients with panuveitis. Biochem Biophys Res Commun. 2001;280(4):1169-76.
27. Prasad PS, Levinson RD. In silico prediction of binding of putative antigenic peptides to HLA-DRB1 alleles in Vogt-Koyanagi-Harada disease. Clin Immunol. 2005;116(2):143-8.
28. Kondo I, Yamagata K, Yamaki K, Sakuragi S. [Analysis of the candidate antigen for Harada's disease[. J Jpn Ophthalmol Soc. 1994;98(6):596-603. Japanese.
29. Minoda H, Sakai J, Sugiura M, Imai S, Osato T, Usui M. [High inducibility of Epstein-Barr vírus replication in B lymphocytes in Vogt-Koyanagi-Harada disease]. Nippon Ganka Gakkai Zasshi. 1999;103(4):289-96. Japanese.
30. Sugita S, Takase H, Imai Y, Mochizuki M. Immunopathogenic mechanisms of a melanocyte-specific autoimmune disease: a cross-reaction between tyrosinase peptides and cytomegalovirus antigen. Invest Ophthalmol Vis Sci. 2002; 43:E-abstract 1529
31. Chan CC, Palestine AG, Nussenblatt RB, Roberge FG, Benezra D. Antiretinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease and sympathetic ophthalmia. Ophthalmology. 1985;92(8):1025-8.
32. de Smet MD, Yamamoto JH, Mochizuki M, Gery I, Singh VK, Shinohara T, et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol 1990;110(2):135-42.
33. Yang P, Chen L, Zhou H, Zhong H, Wang H, Huang X, et al. Resistance of lymphocytes to Fas-mediated apoptosis in Behcet's disease and Vogt-Koyanagi-Harada syndrome. Ocul Immunol Inflamm. 2002:10(1):47-52.
34. Ohta K, Yoshimura N. Bcl-2 expression by CD4 T lymphocytes in Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2002;10(2):93-103.
35. Chee SP, Luu CD, Cheng CL, Lim WK, Jap A. Visual function in Vogt-Koyanagi-Harada patients. Graefes Arch Clin Exp Ophthalmol. 2005;243(8): 785-90.
36. Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology. 2001;108(1):54-64.
37. Bacsal K, Wen DS, Chee SP. Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2008;145(3):480-6.
38. Kawakami Y, Suzuki Y, Shofuda T, Kiniwa Y, Inozume T, Dan K, et al. T cell immune responses against melanoma and melanocytes in cancer and autoimmunity. Pigment Cell Res. 2000;13(Suppl 8):163-9.
39. Kobayashi H, Kokubo T, Takahashi M, Sato K, Miyokawa N, Kimura S, et al. Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient. Immunogenetics. 1998;47(5):398-403.
40. Yamaki K, Kondo I, Nakamura H, Miyano M, Konno S, Sakuragi S. Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats. Exp Eye Res. 2000;71(4):361-9.